» Articles » PMID: 16247051

Cognitive Profile of Patients with Newly Diagnosed Parkinson Disease

Overview
Journal Neurology
Specialty Neurology
Date 2005 Oct 26
PMID 16247051
Citations 349
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the frequency and pattern of cognitive dysfunction in patients with newly diagnosed Parkinson disease (PD) and to identify its demographic and clinical correlates.

Methods: A cohort of 115 consecutive patients with newly diagnosed PD and 70 healthy controls underwent a comprehensive neuropsychological assessment including tests of psychomotor speed, attention, language, memory, executive and visuospatial functions, as well as measures of affective status. Patients also received quantitative ratings of motor symptom severity and functional status. Neuropsychological performance of PD patients was compared with that of healthy controls and with available normative data. Independent demographic and clinical predictors of cognitive impairment were identified with multiple logistic regression analysis.

Results: Relative to controls, PD patients performed significantly worse on most cognitive measures. However, further analysis revealed that group differences in cognitive performance could mainly be explained by measures of immediate memory and executive function. Comparison with normative data showed that impairments were most frequent on measures of executive function, memory and psychomotor speed. In all, 24% of PD patients (4% of controls) displayed defective performance on at least three neuropsychological tests and were classified as cognitively impaired. Late onset of disease was an independent predictor of cognitive dysfunction in PD.

Conclusion: Cognitive impairments are common even in newly diagnosed Parkinson disease patients, with deficits being most prominent in the domains of memory and executive functions. Older age at disease onset is likely to be an important determinant of cognitive dysfunction in Parkinson disease.

Citing Articles

Efficacy of transcranial direct current stimulation on cognitive function in patients with Parkinson's disease: a systematic review and meta-analysis.

Ma S, Zhuang W, Wang X, Zhang D, Wang H, Han Q Front Aging Neurosci. 2025; 17:1495492.

PMID: 40046783 PMC: 11880240. DOI: 10.3389/fnagi.2025.1495492.


Parkinson's disease and deep brain stimulation of the subthalamic nucleus (STN-DBS): long-term disease evaluation and neuropsychological outcomes in a 9-year matched-controlled study.

Cabrera-Montes J, Sanz-Arranz A, Hernandez-Vicente J, Lara-Almunia M Neurosurg Rev. 2025; 48(1):74.

PMID: 39847189 DOI: 10.1007/s10143-025-03231-8.


Alteration in EEG Delta and Beta Power During Working Memory Performance Differentiates Patients with Parkinson's Disease with and without Dementia.

Pal A, Behari M, Sharma R Ann Indian Acad Neurol. 2024; 27(6):663-667.

PMID: 39655467 PMC: 11745243. DOI: 10.4103/aian.aian_198_24.


Epigenomic and clinical analyses of striatal DAT binding in healthy individuals reveal well-known loci of Parkinson's disease.

Yaghoobi A, Seyedmirzaei H, Jamaat M, Ala M Heliyon. 2024; 10(23):e40618.

PMID: 39654757 PMC: 11625257. DOI: 10.1016/j.heliyon.2024.e40618.


Non-invasive brain stimulation enhances motor and cognitive performances during dual tasks in patients with Parkinson's disease: a systematic review and meta-analysis.

Lee H, Choi B, Kang N J Neuroeng Rehabil. 2024; 21(1):205.

PMID: 39581969 PMC: 11587594. DOI: 10.1186/s12984-024-01505-8.